These findings support a hypothesis whereby gains in NAALADL2 and TBL1XR1 concomitantly bring about mRNA expression changes which support an aggressive pro-proliferative phenotype in primary prostate cancer. The gene discussed is TBL1XR1; the disease is Familial prostate cancer.